Company / Working Capital per Share
Xeris Biopharma Holdings, Inc. Working Capital per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.87
FY2025
5-year range
$0.45 / $1.49
FY2021-FY2025
Trend
+79.8%
vs FY2024
Sector context
#185 of 210
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s working capital per share of $0.87 is lower than 88% of companies in the Health Care sector (FY2025). Improved from $0.45 to $0.87 over the past 2 years.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of -21.4%.
Improved from $0.45 to $0.87 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -21.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 210This company $0.87 Sector average $146.86
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 79.8% year-over-year.
- Ranks #185 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | +79.8% |
| FY2024 | $0.49 | +8.6% |
| FY2023 | $0.45 | -50.6% |
| FY2022 | $0.91 | -39.2% |
| FY2021 | $1.49 | -48.7% |
| FY2020 | $2.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026